182 related articles for article (PubMed ID: 20393006)
21. Correlation between RhoA overexpression and tumour progression in esophageal squamous cell carcinoma.
Faried A; Nakajima M; Sohda M; Miyazaki T; Kato H; Kuwano H
Eur J Surg Oncol; 2005 May; 31(4):410-4. PubMed ID: 15837049
[TBL] [Abstract][Full Text] [Related]
22. Expression of CXCL12/CXCR4 and its correlation to prognosis in esophageal squamous cell carcinoma.
Wang DF; Lou N; Zeng CG; Zhang X; Chen FJ
Ai Zheng; 2009 Feb; 28(2):154-8. PubMed ID: 19550128
[TBL] [Abstract][Full Text] [Related]
23. A new proliferation marker, minichromosome maintenance protein 2, is associated with tumor aggressiveness in esophageal squamous cell carcinoma.
Kato H; Miyazaki T; Fukai Y; Nakajima M; Sohda M; Takita J; Masuda N; Fukuchi M; Manda R; Ojima H; Tsukada K; Asao T; Kuwano H
J Surg Oncol; 2003 Sep; 84(1):24-30. PubMed ID: 12949987
[TBL] [Abstract][Full Text] [Related]
24. Dickkopf-1 expression as a marker for predicting clinical outcome in esophageal squamous cell carcinoma.
Makino T; Yamasaki M; Takemasa I; Takeno A; Nakamura Y; Miyata H; Takiguchi S; Fujiwara Y; Matsuura N; Mori M; Doki Y
Ann Surg Oncol; 2009 Jul; 16(7):2058-64. PubMed ID: 19408050
[TBL] [Abstract][Full Text] [Related]
25. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
[TBL] [Abstract][Full Text] [Related]
26. VEGF-C expression correlates with histological differentiation and metastasis in squamous cell carcinoma of the esophagus.
Noguchi T; Takeno S; Shibata T; Uchida Y; Yokoyama S; Müller W
Oncol Rep; 2002; 9(5):995-9. PubMed ID: 12168062
[TBL] [Abstract][Full Text] [Related]
27. [Expression of fascin and cytokeratin 14 in esophageal squamous cell carcinoma].
Xue LY; Song YM; Tong T; Luo W; Dong LJ; Zou SM; Zheng S; Bi R; Zhan QM; Lü N
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(35):2494-8. PubMed ID: 18067814
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic significance of expression of cyclooxygenase-2 in human esophageal squamous cell carcinoma.
Hashimoto N; Inayama M; Fujishima M; Shiozaki H
Hepatogastroenterology; 2007; 54(75):758-60. PubMed ID: 17591056
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological significance of vascular endothelial growth factor-C and cyclooxygenase-2 in esophageal squamous cell carcinoma.
Byeon JS; Jung HY; Lee YJ; Lee D; Lee GH; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI; Kim JS
J Gastroenterol Hepatol; 2004 Jun; 19(6):648-54. PubMed ID: 15151619
[TBL] [Abstract][Full Text] [Related]
30. The molecular role of Fra-1 and its prognostic significance in human esophageal squamous cell carcinoma.
Usui A; Hoshino I; Akutsu Y; Sakata H; Nishimori T; Murakami K; Kano M; Shuto K; Matsubara H
Cancer; 2012 Jul; 118(13):3387-96. PubMed ID: 22028113
[TBL] [Abstract][Full Text] [Related]
31. Cyclooxygenase-2 expression is related to prognosis in patients with esophageal squamous cell carcinoma.
Takatori H; Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Setoyama T; Sasaki K; Tamotsu K; Owaki T; Ishigami S; Aikou T
Eur J Surg Oncol; 2008 Apr; 34(4):397-402. PubMed ID: 17553653
[TBL] [Abstract][Full Text] [Related]
32. [Expression of p53 and vascular endothelial growth factor in esophageal squamous cell carcinoma and their clinical significance].
Liu DB; Chen KN; Cao XZ; Wang T
Ai Zheng; 2002 Sep; 21(9):989-93. PubMed ID: 12508548
[TBL] [Abstract][Full Text] [Related]
33. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma.
Kuo KT; Wang HW; Chou TY; Hsu WH; Hsu HS; Lin CH; Wang LS
Ann Surg Oncol; 2009 Feb; 16(2):352-60. PubMed ID: 19050969
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
[TBL] [Abstract][Full Text] [Related]
35. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
[TBL] [Abstract][Full Text] [Related]
36. Expression and prognostic significance of S100A2 protein in squamous cell carcinoma of the esophagus.
Kyriazanos ID; Tachibana M; Dhar DK; Shibakita M; Ono T; Kohno H; Nagasue N
Oncol Rep; 2002; 9(3):503-10. PubMed ID: 11956617
[TBL] [Abstract][Full Text] [Related]
37. Correlation of visinin-like-protein-1 expression with clinicopathological features in squamous cell carcinoma of the esophagus.
Wickborn C; Klein-Szanto AJ; Schlag PM; Braunewell KH
Mol Carcinog; 2006 Aug; 45(8):572-81. PubMed ID: 16683251
[TBL] [Abstract][Full Text] [Related]
38. A novel gene, RSRC2, inhibits cell proliferation and affects survival in esophageal cancer patients.
Kurehara H; Ishiguro H; Kimura M; Mitsui A; Ando T; Sugito N; Mori R; Takashima N; Ogawa R; Fujii Y; Kuwabara Y
Int J Oncol; 2007 Feb; 30(2):421-8. PubMed ID: 17203224
[TBL] [Abstract][Full Text] [Related]
39. Elevated expression of Rad51 is correlated with decreased survival in resectable esophageal squamous cell carcinoma.
Li Y; Yu H; Luo RZ; Zhang Y; Zhang MF; Wang X; Jia WH
J Surg Oncol; 2011 Nov; 104(6):617-22. PubMed ID: 21744352
[TBL] [Abstract][Full Text] [Related]
40. Reduced membranous beta-catenin protein expression is associated with metastasis and poor prognosis in squamous cell carcinoma of the esophagus.
Hsu PK; Li AF; Wang YC; Hsieh CC; Huang MH; Hsu WH; Hsu HS
J Thorac Cardiovasc Surg; 2008 May; 135(5):1029-35. PubMed ID: 18455580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
